Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK).

Autor: Mueller, Ruediger B., Gengenbacher, Michael, Richter, Symi, Dudler, Jean, Möller, Burkhard, von Kempis, Johannes
Zdroj: Arthritis Research & Therapy; 4/14/2016, Vol. 18, p1-6, 6p
Databáze: Complementary Index
Externí odkaz: